Page last updated: 2024-11-13
isookanin
Description
isookanin: from Bidens bipinnata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Flora | Rank | Flora Definition | Family | Family Definition |
Bidens | genus | A plant genus of the family ASTERACEAE. Members contain bidensyneosides (polyacetylene glucosides).[MeSH] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
Cross-References
Synonyms (14)
Synonym |
isookanin |
1036-49-3 |
3',4',7,8-tetrahydroxyflavanone |
(s)-2-(3,4-dihydroxyphenyl)-7,8 dihydroxychroman-4-one |
Q63396561 |
(s)-2-(3,4-dihydroxyphenyl)-7,8-dihydroxychroman-4-one |
D85185 |
(2s)-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-2,3-dihydrochromen-4-one |
(2s)-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-3,4-dihydro-2h-1-benzopyran-4-one |
CS-0135184 |
HY-N7677 |
CHEMBL4747567 |
AKOS040760476 |
FS-7142 |
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
AID1698073 | Neuroprotective activity against glutamate-induced cell death in mouse HT-22 cells assessed as increase in cell viability after 24 hrs by EZ-Cytox assay | | | |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 4 (57.14) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.35
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 20.35 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.80 (4.65) | Search Engine Demand Index | 15.26 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |